Cargando…

Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China

Alzheimer's disease is the most common neurodegenerative disease. Prior to 2017, National Medical Products Administration approved only four drugs to treat Alzheimer's disease, including three cholinesterase inhibitors and one N-methyl-D-aspartate receptor antagonist. We queried ClinicalTr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yuxia, Yu, Feng, Lyu, Yi, Lu, Xianfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706102/ https://www.ncbi.nlm.nih.gov/pubmed/36457865 http://dx.doi.org/10.3389/fneur.2022.1034243

Ejemplares similares

Drug candidates in clinical trials for Alzheimer’s disease
por: Hung, Shih-Ya, et al.
Publicado: (2017)

The clinical correlation between Alzheimer's disease and epilepsy
por: Zhang, Dandan, et al.
Publicado: (2022)

Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
por: de Aquino, Camila Henriques
Publicado: (2021)

Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis
por: Lyu, Diyang, et al.
Publicado: (2021)

Promising Biomarker Candidates for Cardioembolic Stroke Etiology. A Brief Narrative Review and Current Opinion
por: Markus, Arnold, et al.
Publicado: (2021)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

The Neurocognitive Effects of Ghrelin-induced Signaling on the Hippocampus: A Promising Approach to Alzheimer’s Disease
por: Seminara, Robert S, et al.
Publicado: (2018)

Editorial: Vascular Factors and Vascular Lesions in Pre-clinical Alzheimer's Disease
por: Malek-Ahmadi, Michael, et al.
Publicado: (2021)

Alzheimer’s Disease: A Clinical Practice-Oriented Review
por: Alves, Luísa, et al.
Publicado: (2012)

Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect
por: Ansari, Niloufar, et al.
Publicado: (2013)

Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
por: Hodes, John F., et al.
Publicado: (2019)

Differences in treatment for Alzheimer's disease between urban and rural areas in China
por: Li, Bei, et al.
Publicado: (2022)

Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China
por: Hu, Chaoping, et al.
Publicado: (2020)

Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
por: Agahi, Azadeh, et al.
Publicado: (2018)

The procognitive effects of leptin in the brain and their clinical implications
por: Paz-Filho, G, et al.
Publicado: (2010)

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
por: Limphaibool, Nattakarn, et al.
Publicado: (2019)

Corrigendum: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
por: Agahi, Azadeh, et al.
Publicado: (2019)

Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
por: Leblhuber, Friedrich, et al.
Publicado: (2019)

Analysis of Prognostic Risk Factors for Ischemic Stroke in China: A Multicentre Retrospective Clinical Study; A National Survey in China
por: Cao, Yuting, et al.
Publicado: (2022)

PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease
por: Joshi, Rajeshree, et al.
Publicado: (2019)

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
por: Alghamdi, Saad, et al.
Publicado: (2020)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
por: Gouilly, Dominique, et al.
Publicado: (2023)

Coagulation in Brain Tumors: Biological Basis and Clinical Implications
por: Mandoj, Chiara, et al.
Publicado: (2019)

Clinical Characteristics and Long-Term Prognosis of Anti-LGI1 Encephalitis: A Single-Center Cohort Study in Beijing, China
por: Li, Tao-Ran, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
por: Bhatia, Shiveena, et al.
Publicado: (2022)

Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia
por: Norise, Catherine, et al.
Publicado: (2019)

Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
por: Ikeda, Masaki, et al.
Publicado: (2021)

Editorial: Multimodal interventions in Alzheimer's disease: from basic research to clinical practice
por: Zhang, Tongtong, et al.
Publicado: (2023)

Locating Organizations and Their Methods in Registrations of Clinical Migraine Trials: Analysis of ClinicalTrials.gov
por: Zhang, Pengfei, et al.
Publicado: (2021)

Chronic Neuroinflammation in Alzheimer's Disease: New Perspectives on Animal Models and Promising Candidate Drugs
por: Millington, Christopher, et al.
Publicado: (2014)

AMBAR, an Encouraging Alzheimer's Trial That Raises Questions
por: Loeffler, David A.
Publicado: (2020)

Assessment of factors influencing glymphatic activity and implications for clinical medicine
por: Gędek, Adam, et al.
Publicado: (2023)

New insights and potential clinical implications of the odds ratio product
por: Younes, Magdy
Publicado: (2023)

Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials
por: Wang, Qinghui, et al.
Publicado: (2023)

Transauricular vagus nerve stimulation for patients with disorders of consciousness: A randomized controlled clinical trial
por: Zhou, Yi-Fan, et al.
Publicado: (2023)

Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
por: Lyu, Diyang, et al.
Publicado: (2021)

Effects of High Dose of Atorvastatin for Preventing Periprocedural Ischemic Brain Damage in Patients Undergoing Carotid Artery Stenting (PICAS) in China: A Randomized Controlled Clinical Trial
por: Wang, Haipeng, et al.
Publicado: (2020)

The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum
por: Filardi, Marco, et al.
Publicado: (2022)

Surface-based correlates of cognition along the Alzheimer's continuum in a memory clinic population
por: Coleman, Michelle M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_feg95imcbig8ksc9u100n5roeh